3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Neoplasms
1
Metastatic Pancreatic Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Pancreatic Cancer
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
sonidegib
1
sodium thiosulfate
1
ensartinib
1
cixutumumab
1
cabozantinib
1
Restraint, Physical
1
Pharmacogenomic Variants
1
MLN 8237
1
Cyproheptadine
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatoblastoma
×
irinotecan sucrosofate
×
Clear all
No trials found.